These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13236742)

  • 21. Experience with hormone treatment in some organic nervous diseases.
    JONSSON B; VON REIS V; SAHLGREN E
    Acta Psychiatr Neurol Scand Suppl; 1951; 74():66-9. PubMed ID: 14902542
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple sclerosis; failure of treatment with orally administered digestive enzymes.
    FRIEDMAN AJ
    Calif Med; 1957 Jul; 87(1):29-31. PubMed ID: 13446741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current evidence and therapeutic strategies for multiple sclerosis.
    Wingerchuk DM
    Semin Neurol; 2008 Feb; 28(1):56-68. PubMed ID: 18256987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recommendations for optimising the treatment of multiple sclerosis in Latin America].
    Cristiano E; Arcega R; Correale J; Gabbay AA; Lander-Delgado R; Macias-Islas MA; Palacios E; Patrucco L; Rivera-Olmos V; Soto A
    Rev Neurol; 2007 Apr 16-30; 44(8):494-8. PubMed ID: 17455164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing symptoms of multiple sclerosis.
    Schapiro RT
    Neurol Clin; 2005 Feb; 23(1):177-87, vii. PubMed ID: 15661093
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of neuropsychiatric conditions associated with multiple sclerosis.
    Ameis SH; Feinstein A
    Expert Rev Neurother; 2006 Oct; 6(10):1555-67. PubMed ID: 17078794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].
    Créange A; Farge-Bancel D
    Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D; Slavin S
    J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of multiple sclerosis].
    Vasilescu N; Bulandra R; Ionescu M
    Neurol Psihiatr Neurochir; 1968; 13(6):521-31. PubMed ID: 5719427
    [No Abstract]   [Full Text] [Related]  

  • 30. A successful treatment for multiple sclerosis patients.
    HESS GH
    Northwest Med; 1959 Mar; 58(3):377-82. PubMed ID: 13644762
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple sclerosis in children: clinical, diagnostic, and therapeutic aspects.
    Rostásy K
    Int Rev Neurobiol; 2007; 79():269-79. PubMed ID: 17531845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Despair of repair.
    Stangel M; Hartung HP
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):1-4. PubMed ID: 11784815
    [No Abstract]   [Full Text] [Related]  

  • 33. Passive mechanical properties of gastrocnemius in people with multiple sclerosis.
    Hoang P; Saboisky JP; Gandevia SC; Herbert RD
    Clin Biomech (Bristol, Avon); 2009 Mar; 24(3):291-8. PubMed ID: 19185961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: implications for treatment.
    Pittock SJ
    Neurology; 2007 Feb; 68(7):480-1. PubMed ID: 17296911
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis].
    Saida T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):796-8. PubMed ID: 15651294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine.
    Airas L; Niemelä J; Yegutkin G; Jalkanen S
    Ann N Y Acad Sci; 2007 Sep; 1110():641-8. PubMed ID: 17911479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanodelivery of myelin: a therapeutic option for multiple sclerosis.
    Dharamkar AK
    Med Hypotheses; 2008 Aug; 71(2):318-9. PubMed ID: 18423891
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Future possibilities of the multiple sclerosis treatment].
    Havrdová E; Horáková D; Kovárová I; Krasulová E
    Cas Lek Cesk; 2005; 144(10):663-5. PubMed ID: 16279429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.